Last Updated: Sunday, September 22, 2013, 12:35
The regulators said action will be taken after assessing the FDA's reply.
Last Updated: Friday, September 20, 2013, 22:46
Drug major Ranbaxy Laboratories Friday sought to assuage concerns of shareholders in the wake of company's stock price taking a hard knock after the US Food and Drug Administration banned the import of drugs from its Mohali plant.
Last Updated: Tuesday, September 17, 2013, 19:16
"The FDA also ordered that the Mohali facility be subject to certain terms of the consent decree of permanent injunction entered against Ranbaxy in January 2012," according to United States Food and Drug Administration website.
Last Updated: Monday, September 16, 2013, 23:54
"The firm will remain on the import alert until the company complies with U.S. Drug manufacturing requirements, known as current good manufacturing practices (CGMP)," USFDA said in a statement.
Last Updated: Monday, September 16, 2013, 10:03
A third Ranbaxy Laboratories plant in India has been sanctioned with an import alert ban from the US Food and Drug Administration, triggering the worst single day fall in its stock on Monday and a brokerage downgrade.
Last Updated: Monday, June 24, 2013, 12:30
Shares of Ranbaxy Laboratories Monday dipped by nearly 7 percent on reports that the company's manufacturing facility at Mohali has come under the USFDA's scanner.
Last Updated: Friday, June 07, 2013, 15:57
Backing pharma major Ranbaxy, who has been accused of marketing sub-standard medicines, the health ministry Friday said there was nothing wrong with the quality of its drugs.
Last Updated: Wednesday, June 05, 2013, 19:01
Generic drugs distributed in South Africa by Indian pharmaceutical giant Ranbaxy are "safe" and "efficacious", the country's regulator body said Wednesday, days after the beleaguered drug maker paid a fine of USD 500 million in the US for selling adulterated drugs there.
Last Updated: Wednesday, June 05, 2013, 18:58
An advocate Wednesday approached the Supreme Court with a PIL seeking cancellation of the license granted to Ranbaxy Laboratories Ltd and for initiating probe against the pharma major for allegedly manufacturing and selling adulterated drugs.
Last Updated: Saturday, March 31, 2012, 13:30
Indian generic drug maker Ranbaxy Laboratories Ltd. said Saturday that its subsidiary in Canada got an approval from Health Canada to manufacture and market Ran-Rosuvastatin tablets, a cholesterol-lowering medication, to the Canadian healthcare system.
Last Updated: Thursday, February 23, 2012, 16:49
Ranbaxy Laboratories Ltd, India's top drugmaker by sales, reported a quarterly loss of Rs 29.83 billion, mainly due to a provision related to a probe by the US Justice Department.
Last Updated: Wednesday, December 21, 2011, 11:00
Shares of Ranbaxy Laboratories Ltd fell more than 3 percent on Wednesday after the Indian drugmaker said it had reached an agreement with the US Food and Drug Administration to comply with US manufacturing practices.
more videos >>